National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

synthetic human corticotropin-releasing factor
A synthetic therapeutic agent which is chemically identical to or similar to the endogenous human corticotropin-releasing factor (hCRF). Synthesized in the hypothalamus, hCRF stimulates the anterior pituitary gland to secrete adrenocorticotropic hormone (ACTH). In cerebral edema, hCRF acts by impeding the flow of fluid from blood vessels into brain tissue, thereby decreasing edema and stabilizing intracranial pressure. This agent possesses anti-edema properties independent of adrenal gland function. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonyms:corticoliberin
corticorelin
hCRF
recombinant human corticotropin releasing factor
therapeutic human corticotropin releasing factor
US brand name:Xerecept



Previous:Symmetrel, Synestrin, Synovir, synthetic brain tumor peptides-pulsed autologous dendritic cell vaccine, synthetic breast cancer peptides-tetanus toxoid-Montanide ISA-51 vaccine
Next:synthetic human papillomavirus 16 E6 peptide, synthetic melanoma-associated antigens vaccine, synthetic peptide-based erythropoiesis stimulating agent, synthetic peptides E-PRA and E-PSM vaccine, Synthoestrin

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov